Lab Notes: Adaptimmune to expand manufacturing at Navy Yard; Helius raises $18M with stock sale
August 12, 2022 at 11:42 AM EDT
A Philadelphia biotechnology company gets orphan drug status for its new drug candidate.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|